AU2015308695B2 - Vaccine for livestock production systems - Google Patents

Vaccine for livestock production systems Download PDF

Info

Publication number
AU2015308695B2
AU2015308695B2 AU2015308695A AU2015308695A AU2015308695B2 AU 2015308695 B2 AU2015308695 B2 AU 2015308695B2 AU 2015308695 A AU2015308695 A AU 2015308695A AU 2015308695 A AU2015308695 A AU 2015308695A AU 2015308695 B2 AU2015308695 B2 AU 2015308695B2
Authority
AU
Australia
Prior art keywords
dam
salmonella
vaccine
microorganism
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2015308695A
Other languages
English (en)
Other versions
AU2015308695A1 (en
Inventor
Douglas HEITHOFF
Michael Mahan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California, San Diego
Original Assignee
University of California Berkeley
University of California, San Diego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California, San Diego filed Critical University of California Berkeley
Publication of AU2015308695A1 publication Critical patent/AU2015308695A1/en
Application granted granted Critical
Publication of AU2015308695B2 publication Critical patent/AU2015308695B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K29/00—Other apparatus for animal husbandry
    • A01K29/005—Monitoring or measuring activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/42—Salmonella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Environmental Sciences (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
AU2015308695A 2014-08-29 2015-08-28 Vaccine for livestock production systems Ceased AU2015308695B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462043459P 2014-08-29 2014-08-29
US62/043,459 2014-08-29
PCT/US2015/047549 WO2016033532A1 (en) 2014-08-29 2015-08-28 Vaccine for livestock production systems

Publications (2)

Publication Number Publication Date
AU2015308695A1 AU2015308695A1 (en) 2017-03-09
AU2015308695B2 true AU2015308695B2 (en) 2020-11-05

Family

ID=55400708

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015308695A Ceased AU2015308695B2 (en) 2014-08-29 2015-08-28 Vaccine for livestock production systems

Country Status (11)

Country Link
US (1) US10329552B2 (enExample)
EP (1) EP3186363B1 (enExample)
JP (1) JP6683684B2 (enExample)
CN (1) CN106661544B (enExample)
AU (1) AU2015308695B2 (enExample)
BR (1) BR112017003275A2 (enExample)
CA (1) CA2958892C (enExample)
MX (1) MX381343B (enExample)
RU (1) RU2723031C2 (enExample)
WO (1) WO2016033532A1 (enExample)
ZA (1) ZA201701081B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112618706B (zh) * 2020-11-21 2021-09-14 青岛博霖生物科技有限公司 沙门氏菌、鸭疫里默氏杆菌、大肠埃希氏杆菌病三联疫苗
KR102775394B1 (ko) * 2021-10-26 2025-02-28 전북대학교산학협력단 waaJ 유전자 및 spiC 유전자 중 적어도 하나가 결실된 살모넬라 변이균주, 이의 제조 방법 및 이를 함유하는 살모넬라 생백신 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020068068A1 (en) * 1999-02-02 2002-06-06 Mahan Michael J. Method of creating antibodies and compositions used for same
US20020086032A1 (en) * 1999-02-02 2002-07-04 Mahan Michael J. Producing antibodies with attenuated bacteria with altered DNA adenine methylase activity
EP1245679A4 (en) * 1999-12-21 2005-03-16 Japan Science & Tech Agency IMPF STAMPS AGAINST INFECTIONS WITH PATHOGENIC BACTERIA
NZ519477A (en) * 1999-12-23 2004-04-30 Microscience Ltd Attenuated microorganisms for the treatment of infection
AU2001292035A1 (en) * 2000-09-29 2002-04-08 Microscience Limited Attenuated salmonella microorganisms comprising a mutation in the sifa gene
ES2345200T3 (es) * 2003-03-24 2010-09-17 The Scripps Research Institute Vacunas de adn contra el crecimiento tumoral y procedimientos de utilizacion de las mismas.
US7569552B2 (en) * 2003-10-08 2009-08-04 The Scripps Research Institute DNA vaccines against tumor growth and methods of use therof
US8761034B2 (en) 2008-02-27 2014-06-24 Telefonaktiebolaget L M Ericsson (Publ) System and method of demultiplexing provider backbone bridging traffic engineering instances

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
B. R. SINGH, "Salmonella Vaccines for Animals and Birds and Their Future Perspective", THE OPEN VACCINE JOURNAL, (2009-08-03), vol. 2, no. 1, doi:10.2174/1875035400902010100, ISSN 1875-0354, pages 100 - 112 *
BADIE GOLNAZ ET AL, JOURNAL OF BACTERIOLOGY MAR 2007, (2007-03), vol. 189, no. 5, ISSN 0021-9193, pages 1556 - 1564 *

Also Published As

Publication number Publication date
RU2017110230A3 (enExample) 2019-04-24
RU2017110230A (ru) 2018-10-01
CA2958892C (en) 2023-01-24
BR112017003275A2 (pt) 2017-11-28
WO2016033532A1 (en) 2016-03-03
JP6683684B2 (ja) 2020-04-22
EP3186363A4 (en) 2018-04-11
ZA201701081B (en) 2020-11-25
CN106661544B (zh) 2020-03-27
MX381343B (es) 2025-03-12
EP3186363A1 (en) 2017-07-05
RU2723031C2 (ru) 2020-06-08
US20170267994A1 (en) 2017-09-21
US10329552B2 (en) 2019-06-25
AU2015308695A1 (en) 2017-03-09
NZ729153A (en) 2022-03-25
JP2017525726A (ja) 2017-09-07
CN106661544A (zh) 2017-05-10
CA2958892A1 (en) 2016-03-03
EP3186363B1 (en) 2020-04-22
MX2017002594A (es) 2017-05-19

Similar Documents

Publication Publication Date Title
EP2528620B1 (en) Salmonella vaccine
Methner et al. Intestinal colonisation-inhibition and virulence of Salmonella phoP, rpoS and ompC deletion mutants in chickens
AU2001256957B2 (en) Salmonella vaccine materials and methods
Karasova et al. Comparative analysis of Salmonella enterica serovar Enteritidis mutants with a vaccine potential
Edrees et al. Construction and evaluation of type III secretion system mutants of the catfish pathogen Edwardsiella piscicida
Heithoff et al. Development of a Salmonella cross-protective vaccine for food animal production systems
US9125855B2 (en) Prevention of Salmonella recrudescense
US8858930B2 (en) Live attenuated bacterial vaccine to reduce or inhibit carriage and shedding of enterohemorrhagic Escherichia coli in cattle
US20050019335A1 (en) Salmonella vaccine
JP2009531029A (ja) 弱毒化サルモネラ生ワクチン
CA2958892C (en) Vaccine for livestock production systems
US20020086032A1 (en) Producing antibodies with attenuated bacteria with altered DNA adenine methylase activity
NZ729153B2 (en) Vaccine for livestock production systems
Yang Experimental Approaches to Understand and Control Salmonella Infection in Poultry
KARTHIK CHARACTERIZATION OF Clostridium chauvoei ΔcctA MUTANT AND EVALUATION OF ITS VACCINE POTENTIAL
KR20080105099A (ko) 약독화 살모넬라 생백신
Terhorst Systemic infection induced by Campylobacter jejuni: Development of a mouse model and elucidation of molecular mechanisms
Kachooei Immune responses of calves after vaccination with a live attenuated derivative of Pasteurella multocida B: 2
Heithoff et al. Intraspecies Variation in the Emergence of Hyperinfectious Bacterial Strains in
Neal-McKinney Elucidation of Campylobacter pathogenesis in humans and commensal colonization in chickens
AU2002223922A1 (en) Salmonella vaccine

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired